Importantly, our findings identify 3‐HKA as a critical regulator of vascular remodeling after cerebral ischemia via the regulation of the astrocyte A1/A2 transition by impeding AIM2 inflammasome activation and suggest that supplementation with 3‐HKA may be efficient in the therapeutic management of stroke. Here, AIM2 is linked to stroke disorder.